bachem
glassdoor has 30 bachem reviews submitted anonymously by bachem employees. read employee reviews and ratings on glassdoor to decide if bachem is right for you .
in 2007, bachem aquired the clinalfa® brand for bachem' s ready - to - use clinical trial materials and related services .
bachem began in 1971, when peter grogg founded bachem feinchemikalien ag with two employees in liestal near basel with the focus on peptide synthesis .
bachem – insights into peptide chemistry achievements by th... : ingenta connect
affiliations: bachem ag, hauptstr. 144, ch - 4416 bubendorf, switzerland
thank you for taking the time to provide us your feedback. while we regret that your experience with bachem did not meet your expectations, bachem considers all feedback provided in glassdoor reviews
we are delighted to welcome you to bachem and invite you to learn more about our company .
between 1957 and 2001, bachem life expectancy was at its lowest point in 1995, and highest in 1996. the average life expectancy for bachem in 1957 was 85, and 89 in 2001 .
this section is a placeholder for information about the bachem surname. surname information is crowd - sourced; the geni community would be grateful if you helped update this page with information about the bachem surname .
there are already 85 genealogy profiles with the bachem surname on geni. join now to find your relatives .
management team is a priority for bachem. just recently, bachem implemented a new management training program. this program is designed to provide managers at all levels of the company with the tools and skills necessary for success. bachem provides employees with development and growth opportunities by way of expanded responsibilities and challenges. through an accumulation of such experiences with demonstrated success and some patience, opportunties for advancement will come as the company continues to grow. please also recognize that as you gain experience and develop yourself at bachem, you can expect that bachem and its management team will continue to develop and improve. bachem encourages and welcomes feedback and ideas for improvement from all of our employees .
in 2010, the bachem group had total sales of chf 152. 9 million and a headcount of 668 employees .
expansion into markets outside europe began with the establishment of bachem bioscience, inc. in philadelphia, usa in 1987. to strengthen its presence in europe, bachem opened sales and marketing centers in germany in 1988 and in france in 1993. in 1996 it acquired its largest competitor, bachem, inc. , together with its subsidiaries in germany and the united kingdom. in june 1998, following a very successful ipo, bachem' s shares began to be publicly traded on the swiss stock exchange .
bachem is continuously expanding and updating its extensive range of products for your research purposes. find all new catalog products listed here .
in 2010, bachem commenced the partnership with atheris laboratories offering the melusine® range of research products for lead generation of new pharmaceutical candidates .
company bachem is an independent, technology - based, public biochemicals company providing full service to the pharma and biotech industry ...
with the acquisition of the san carlos, california based peninsula laboratories, inc. and its affiliate peninsula laboratories ltd. , united kingdom in december 1999, bachem extended its strong position in therapeutically active peptides into immunology, a domain with strong future promise. in august 2000, peninsula laboratories europe ltd. and bachem (uk) ltd. merged together to a single bachem group affiliated company in the united kingdom .
in 2011, bachem celebrates its 40th year as a producer of research ingredients and active pharmaceutical ingredients (apis) for the pharmaceutical industry .
how much do bachem employees make? glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates .
thank you for taking the time to provide bachem with your feedback. we appreciate your candid perspective on what is good and where improvement is needed .
in 2014, bachem the leading peptide manufacturer, and glytech inc. (kyoto, japan), the world - leading developer of glycosylated drugs, announced today that they have entered into a co - promotion agreement for glytech' s glycosylation technology. as part of the agreement, bachem will leverage its sales and marketing resources to enhance glytech' s partnering efforts and glytech will promote bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins .
no matter where you are located, bachem has the expertise and resources to help you and your organization excel in life science research and pharmaceutical drug development .
in 2015, bachem acquired american peptide company, a us - based specialized manufacturer of peptides. apc provides a wide range of services from small - scale catalog business and custom synthesis to large - scale manufacturing under cgmp. the acquisition of apc strengthens bachem' s expertise and once again expands its manufacturing capabilities .
bachem provides comprehensive services to the pharma and biotech industries. it specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide - based apis. the group has a global reach with more experience and know - how than any other company in the industry. bachem. pioneering partner for peptides
in 1977, bachem moved with eight employees to near - by bubendorf, and, in 1978, it manufactured, for the first time, peptides for use in medicine under cgmp guidelines. between 1981 and 1991 bachem tripled its production capacity and built an administration building, while the number of employees grew to 150 .
the positive feedback is appreciated. competing in a dynamic and demanding industry, bachem strives to create a stimulating work environment that allows individuals to contribute and make a positive
with headquarters in bubendorf, switzerland, and group companies in europe and the us, bachem works on a global scale and holds a leading position in its field. facilities in switzerland and in the us, approved by international regulatory authorities and suitable also for the large scale production of active ingredients, make bachem a partner for all major pharmaceutical companies .
thank you for taking the time to write a review about our organization. bachem recognizes the demanding work environment at the vista facility and recognizes the efforts of all the employees during
census records can tell you a lot of little known facts about your bachem ancestors, such as occupation. occupation can tell you about your ancestor' s social and economic status .
our knowledgeable sales and service representatives are ready to help you with any questions you may have. below you will find the appropriate contact information for the bachem sales office in your region :
thank you for the feedback. bachem is an equal opportunity employer, and we are happy to bring recent graduates as well as experienced personnel onboard. the opportunity to learn and grow is
clinalfa® is bachem’s brand name for its sterile products to be used in approved clinical studies. the products are manufactured and released based on the requirements laid down in the relevant european commission directives. clinalfa®
bachem has more than 45 years of continuous experience in producing peptides for research purposes. this expertise allows us to offer you more than 4000 different biologically active peptides, biochemicals, substrates & inhibitors of any complexity right from stock. since its founding in 1971 peptides are the core business of bachem. a great number of highly qualified and skilled peptide scientists work for us to provide you with the highest quality peptides .
census records can give you a fascinating window into the day - to - day lives of your bachem ancestors - like hours worked per week, level of education, veteran status, employers, and more .
the acquisition of sochinaz sa, a swiss - based specialized manufacturer of active pharmaceutical ingredients in 2001, strengthened bachem' s expertise and once again expanded its manufacturing capabilities. the headcount of the group grew at this time to 500 employees .
everything started with a craft business founded near bad waldsee in 1923. back then alfons hymer worked as a wheelwright and coachbuilder. with a firm resolve to become self - employed one day, his son erwin hymer joined the family business in 1956 and bought part of the bachem premises. working closely with erich bachem, the ur - troll was developed in 1957. as early as the following year, the two men started serial production of the now famous eriba touring series .
if you need products that are not offered from stock, our custom synthesis team is happy to support you in bringing your project from research scale to bulk cgmp active pharmaceutical ingredient (api) utilizing effective technology transfer between bachem locations worldwide. custom synthesis
in 2017, bachem together with a customer accepted the greener reaction conditions award at a national academy of sciences ceremony in washington, d. c. the award was given to recognize the development of a robust, cost - efficient and environmentally friendly manufacturing process for a peptide compound with regulatory approval. bachem’s center of excellence in production of research chemicals in st. helens, uk, has obtained iso certification in 2018 and additional production and analytical labs have been built and equipped with state - of - the - art instruments .
bachem has a wonderful group of people that are helping to grow the company. the benefits are good. i see a lot of potential for growth in the next few years. i’ve learned a lot in my time here and made some great contacts for networking .
bachem offers more than 6500 different biologically active peptides, amino acid derivatives and biochemicals from stock, ready to deliver. these products can be found in our online shop or in our main catalog (peptides, building blocks for peptide synthesis and non - peptidic biochemicals) .
the swiss fine chemicals company bachem, pioneer and specialist in the chemical synthesis of peptides, has also become an internationally leading manufacturer of peptide active pharmaceutical ingredients (apis). in response to increasing demands in scale and purity, bachem' s research efforts centered on the chemistry involved in solid - phase peptide synthesis and the production of the required amino acid derivatives with the aim of a continuous improvement of the technology. the resulting optimized protocols together with high - throughput equipment enabled us to manufacture long peptide apis and, more recently, even pharma - grade glycoproteins in industrial scale .
an unusually short lifespan might indicate that your bachem ancestors lived in harsh conditions. a short lifespan might also indicate health problems that were once prevalent in your family. the ssdi is a searchable database of more than 70 million names. you can find birthdates, death dates, addresses and more .
i enjoy my job at bachem. i would stay here my whole career but with the toxic managers and low pay i can’t imagine i will stay forever. if you can make progress in both of these areas i believe vista will boom in success and productivity and you will lower your turnover rate .
it is our firm wish to maintain an open and honest relationship between potential investors, share holders and bachem. we inform transparently and consequently about all relevant facts; according to our internal guidelines and all statutory laws and guidelines. investor relations has to prepare and provide this information in a timely, correct and meaningful manner. we want to ensure that our shareholders and potential investors get a reliable picture of the bachem group in terms of the current situation and expected future developments. we aim to achieve a basis of trust on which we can build and maintain long term and successful relationships. we are looking forward to working with you .
the past three years as we have made substantial investments to improve the facilities and equipment. bachem is committed to the vista facility and continues to invest a significant amount of time and resources to ensure the success of this site and the development of the organization. the feedback regarding your perception of health and safety at the vista site is appreciated. safety of our employees and workplace is a top priority to bachem. we have every intention to look into this matter and to correct any problems that may be identified. if any employee, at any time, has concerns with safety, i would appreciate the opportunity to discuss these concerns with you .
bachem is specialized in the development and the manufacturing of biologically active peptides and complex organic molecules as active pharmaceutical ingredients (apis) and as innovative biochemicals for research purposes. as market leader, we are able to offer you a wide range of biologically active peptides and biochemicals used in peptide research. our range of research products is organized in the following four categories :
in 2013, glytech, inc. (kyoto, japan) and bachem ag (bubendorf, switzerland) informed that they have successfully co - developed a chemical synthesis of interferon β - 1a applicable for industrial scale. interferon β - 1a is a 166 amino acid long glycosylated protein and an approved drug substance to treat multiple sclerosis with a world market of more than $ 4 billion .
reorganization of distribution was carried out in germany and france as a result of the positive experiences gained with the realignment of the sales and marketing organization in the usa. as a result the subsidiary in france was closed at the end of 2002. the subsidiary in germany was relocated from heidelberg to weil am rhein, was renamed bachem distribution services gmbh and is now responsible for all customers in the european union .
as japanese agent of bachem, the largest independent cmo in the peptide industry and through our successful long term collaboration in the peptide business, we provide a wide range of peptide synthesis services including high quality and high reliability. meeting customers’ various needs, we supply peptide as active pharmaceutical ingredients (apis), as well as innovative biochemicals for research purposes from small - scale (mg) to bulk scale (kg) .
not sure why there are these negative reviews, could be a disgruntled employee or two? but the environment is not like this all. in my experience, 2 years in the vista facility, i have come to find this the place for me. sure there have been some challenges as this is a new facility for bachem, but to be fair these are challenges that come with the territory of acquiring a new facility. i’ve seen the progression and how things seem to be running much more smoothly. people are great, management has a realistic vision, and benefits are great !
positions are advertised internally and externally to provide an opportunity for qualified candidates to apply. through the interview process, the best suited candidates are selected for the roles. we are an equal opportunity organization and we are happy to give all eligible candidates, including recent graduates, an opportunity to work for our organization. we believe that all eligible candidates deserve the chance to learn and gain experience. quality and safety are top priorities of bachem, and we always stress the importance of not compromising quality and safety over business priorities. if you have specific concerns regarding quality and safety, please bring these to the attention of any of the vista management team or even me. together we can build an outstanding organization !
html public
- / / w3c / / dtd xhtml 1. 0 transitional / / en
urltoken
in 1995, facilities were further expanded including the quality control department to a total of 168' 000 sq. ft. (15' 600 m 2), and employees totaled 190 .
the group had total sales of chf 96 million in 1998 and a headcount of 331 employees. in 1999 and 2000, a new administration building and a further production facility were respectively opened at the bubendorf site .
in 2003, a holding structure was introduced to align the factual organization of the company with an appropriate legal structure and to support management structure adjustments, given by continued company growth requirements .
in 2016, operations commenced at the group’s most modern building for r & d projects and small lot production in bubendorf, switzerland. with a total headcount of 1' 022, the company’s workforce passed the 1' 000 mark for the first time in its history .
the selective chemical glycosylation at large scale has potential to be applied to a variety of peptides, where we can pioneer the concept of improving current and future drugs via chemical glycosylation .
javascript seems to be disabled in your browser. you must have javascript enabled in your browser to utilize the functionality of this website .
a wide range of brochures, technical documentation and practical information is available for our products and services .
here you will find answers to frequently asked questions regarding our products and our company .
peptides are chains of amino acids. virtually every life process involves peptides in some way. their key role is to regulate body functions such as the release of hormones, the regulation of blood sugar levels, bone metabolism and various neurological processes. peptides play a key role in the growing segment of biopharmaceuticals. peptide - based drug targets are being identified at an increasingly rapid pace and a variety of new peptide drugs are being developed as novel therapies for cancer, pain treatment, viral infections, diabetes and a host of endocrine and neurological disorders .
glassdoor will not work properly unless browser cookie support is enabled. learn how to enable cookies .
your trust is our top concern, so companies can' t alter or remove reviews .
very exciting time to be a part of this company, as it is entering a phase of expansion. if you’re looking for an exciting opportunity, with growth potential, and where your out of the box thinking is valued, this is the place to be. not the typical boring job, but each day presents new challenges and i look forward to going into work in the morning. also our products help people and it is great to be a part of something that contributes to the well - being of society .
with growth brings many new hires, and so there is the learning curve. but these individuals are top notch and a valuable part to the company’s growth... once everyone gains the necessary experience, our work force will gain a good share of seasoned employees .
management is very transparent and informs employees of new developments. they seem to value their employees much more than my past companies. they have a solid vision and understanding of how they want to achieve growth in the next 5 - 10 years. keep doing what you have been .
while there is lots of growth very little of the advancement seems to come from within. planning seems to be poor many projects feel like last minute rushes. this is exasperated by the fact senior management will just say get it done and pack up after their 9 - 5 or agree to completely ridiculous deadlines since they won’t be doing the work. company morale is not great, most of senior management is toxic. a certain senior executive at the vista site seems to be the primary cause. he consistently bad mouths everyone but contributes nothing as he plays on his cell phone in most meetings. it’s really mentally and emotionally draining and causes lots of unnecessary problems. the pay isn’t competitive with the area which causes a pretty high turnover rate .
there have been some bumps in the road with the transition, but i’m seeing these growing pains as a thing of the past .
they hire a lot of recent graduates, great position to learn and master techniques .
important to career development, and we are happy to be a part of each employee’s growth and success. we understand that not having all the facts can be frustrating, and we are working towards having greater visibility at all levels. with the pressures of the day - to - day work, your manager may not always disseminate information to you. we are making big efforts to improve our communication, with focus on clear, precise, timely and understandable communication. while we work to develop our communication, we ask for and appreciate your patience. if at any time you feel that management communication is not effective, please feel free to let your manager know your impressions and expectations .
got potential due to new management. they will hire people right out of college and hire incompetent managers just because they know someone inside. benefits are okay. thankful for the monthly food offerings. awesome new coffee machine. there are a lot of good valuable and respectable employees .
top heavy. too many upper management babysitting incompetent managers. horrible management. lack of communication from management to subordinates. extremely disorganized. they don' t value employees and everyone is viewed as expendable. no promotion or raises unless you give notice. toxic environment. quality and safety is very questionable. everything is last minute
value, respect, and listen to your employees. assess management and let go of the incompetent ones who does not deserve to be managing people .
thank you for taking the time to provide your feedback. the vista site is a growing organization and like “building a puzzle” it takes time to put all the pieces of the organization in place. open
- upper management doesn' t do anything to fix anything, if at any time you suggest a solution, they consider you a threat and try to demote you. - if you threaten to leave, they' ll promote you, making the people who work hard day in and day out, not get converted to full time or get raises. - you address concerns to corporate and they don' t care because they are in switzerland. they are not public in the u. s. so they don' t care. - upper management hr doesn' t do their job correctly, nepotism at its best, hiring their friends, even if they don' t have qualifications. - high turn - over rates, which means you work harder to cover for those who left. - very toxic environment
it starts with the top of the pyramid, so when upper management doesn' t care, the rest of the pyramid falls apart. there' s high turn - over rates and upper management hr doesn' t do anything about it, hiring people without experiences. lots of cliques are formed, upper management has favorites that they groom and promote. i don' t see this company lasting for more than 10 years, at least not the vista site. it' s a very toxic environment to work in .
good benefits. a lot of smart and talented ground level employees and a few managers who are helpful and work incredibly hard. plenty of opportunities to learn new things .
evaluate your management team, many people in middle to upper management are unqualified or incompetent and make the troop level employees frustrated and exhausted as they have to take on or correct their boss' work. stop rushing every project. stop cutting corners on equipment and building needs. re - evaluate your priorities - sales mean nothing if you can' t complete a product on time or guarantee its quality because equipment was assembled and installed hastily without proper qualification and testing. invest more in your facility .
poor management. lack of direction, communication, knowledge, attention to details. no accountability. people at the management level has no managerial skill set, not enough technical knowledge, not enough compliance knowledge. like many reviews said, there are people at the top, just because they have been with the company for a long time. when things don' t go right, they blame the workers to cover themselves. and you have new people (management) who constantly compare this place to another giant pharma, yet has zero knowledge to lead, quick to blame others, inappropriately holding others accountable for their lack of ability. very sad. stay away from this place. if you work hard, you are expected to work even harder and get blamed if things go wrong. poor planning, poor communication, poor compliance, poor management. sorry for the people who still works there .
as an opportunity to grow and improve. efforts are ongoing to develop enhanced training programs at all levels of the organization, including management levels. it is our continuing goal to create a dynamic and attractive workplace for both our current and future employees, one which provides opportunities for individual growth and development and which recognizes and rewards individual contributions toward common goals .
good medical benefits and the site is located in a great area. suggestions for problems can be seen by management. appreciation for birthdays .
the morale at the site is very low. negativity is spread everyday. in order to change this, it has to be struck at the head or heart or the source, which is management. our concerns are voiced everyday. the number 1 concern at the site is promoting within your own department and then opening the door for outsiders. when an employee wants to leave please let that happen and give an opportunity for others to grab this opportunity to move up. we need moral support from management. the overall pay at the site is very low. when employees perform well, promote and pay. when employees offer real change and positive effects, promote and pay. when employees put in long hours and allow the company to make most of it’s profit for the year in 1 month, promote and pay. this is the greatest morale you can give to the employees. others will follow in line and want to do the best they can do .
this is the employer' s chance to tell you why you should work for them. the information provided is from their perspective .
this will replace the current featured review for targeted profile. are you sure you want to replace it ?
copyright © 2008–2018, glassdoor, inc .
glassdoor
and logo are proprietary trademarks of glassdoor, inc .
upload a resume to easily apply to jobs from anywhere. it' s simple to set up .
know your worth™. get a free, personalized salary estimate based on today' s job market .
glassdoor has millions of jobs plus salary information, company reviews, and interview questions from people on the inside making it easy to find a job that’s right for you .
the website you are about to visit is progenealogists ®, operated by tgn services, llc, a subsidiary of ancestry .
this page needs javascript enabled in order to work properly. click here for instructions on how to enable it in your browse
historically, surnames evolved as a way to sort people into groups - by occupation, place of origin, clan affiliation, patronage, parentage, adoption, and even physical characteristics (like red hair). many of the modern surnames in the dictionary can be traced back to britain and ireland .
privacy & cookies: this site uses cookies. by continuing to use this website, you agree to their use. to find out more, including how to control cookies, see here: cookie policy
geni requires javascript! please enable javascript in your browser' s settings to use this part of geni .
adolph was a german ace during world war i and was one of the original pilots in the 1st german air circus despite having only one good eye .
html public
- / / w3c / / dtd xhtml 1. 0 strict / / en
urltoken
s & p 500 index data: s & p 500 copyright © 2018 currency is displayed in chf .
international sites: australia canada china france germany hong kong italy the netherlands norway spain u. k. switzerland
independent. insightful. trusted. morningstar provides stock market analysis; equity, mutual fund, and etf research, ratings, and picks; portfolio tools; and option, hedge fund, ira, 401k, and 529 plan research. our reliable data and analysis can help both experienced enthusiasts and newcomers. © copyright morningstar, inc. all rights reserved. please read our terms of use and privacy policy. dow jones industrial average, s & p; 500, nasdaq, and morningstar index (market barometer) quotes are real - time. russell 2000 quote is 10 minutes delayed .
we use cookies to ensure that we give you the best experience on our website and to improve our web service. by using our web services, you accept that we use cookies. further information
the significance of the hymer brand name and the fact that a hymer is today a
german standard
epitomising motorhomes in general, like ‘kleenex’ for tissues, has its roots in the hymermobil and in the start of motorhome series production in 1972. this status is based not only on long - standing tradition and experience, however, but on hymer’s persistent aspiration to be a trendsetter in terms of the latest developments .
besides attractive design and a comfortable interior, the focus was always above all on fulfilling customers’ desire for top - quality, innovative technology and optimal safety. as a result, for example, hymer was the first manufacturer, back in 1985 to give a six - year ingression warranty on all its motorhomes. hymer was also a trailblazer in terms of safety, among other things, and in the introduction of the double - floor concept .
and even today, after so many innovations and awards, the company from bad waldsee still pushes the development of the hymbermobils with particular passion – so that the original will always come straight to mind in the future when people think of motorhomes .
registered office address changed from delph court sullivans way st. helens merseyside wa4 5gl on 14 february 2014
registered office address changed from delph court sullivans way st. helens merseyside wa4 5gl on 14 february 2014 - link opens in a new window - 1 page
from now on, we will keep focusing on the development of safe and high quality pharmaceutical products and their stable supply to the market .
in this day and age of the coming of aging society and increasing lifestyle diseases, people are becoming more conscious about self - medication, saying “keep your health by yourself. ” in our functional food business, with a concept of “creating good by eating foods, ” we have been searching for a bioactive component in natural source that is effective for maintaining or improving human health. with such know - how gained through our r & d; activities, l - carnitine, heme - iron, and liver extract have been developed and commercialized. these products are manufactured under a strict quality control system for guaranteeing their safety by monitoring all the production levels from raw materials to final products .
we will provide a continuous support, through our functional food business, to implement the self - medication by offering a new way to get healthy from the field of functional food ingredients .
this site is operated by a business or businesses owned by informa plc and all copyright resides with them. informa plc' s registered office is 5 howick place, london sw1p 1wg. registered in england and wales. number 3099067 .
tides365 oligonucleotide and peptide development professionals knect365. lifesciences tides: oligonucleotide and peptide therapeutics
this website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. by continuing to use our website, you agree to the use of such cookies. click here for more information on our cookie policy and privacy policy .
international journal for chemistry and official membership journal of the swiss chemical society (scs) and its divisions chimia, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. contributions from all fields of chemistry and related areas are considered for publication in the form of review articles and notes. a characteristic feature of chimia are the thematic issues, each devoted to an area of great current significance .
ingenta. article copyright remains with the publisher, society or author (s) as specified within the article .
website makes use of cookies so as to keep track of data that you have filled in .
diese homepage wird gemeinschaftlich betrieben durch die unten weiter spezifizierten organisationen varsity brands europe gmbh, varsity europe sports support ggmbh und varsity europe uk ltd. die organisationen sind gemeinschaftlich verantwortlich für die inhalte dieser homepage.
bachem is a contract manufacturing organization headquartered in bubendorf , switzerland . bachem specializes in the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients . in addition , biochemicals for research purposes and manufacturing processes are developed . the firm provides a number of products and services to the pharmaceutical and life science industries , including organic fine and performance chemicals , custom manufacturing of biopharmaceuticals , chemical synthesis capabilities and new chemical entities , and services for the bioscience sector . 
bachem is a contract manufacturing organization headquartered in bubendorf, switzerland. bachem specializes in the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients. in addition, biochemicals for research purposes and manufacturing processes are developed. the firm provides a number of products and services to the pharmaceutical and life science industries, including organic fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities and new chemical entities, and services for the bioscience sector.
bachem is a contract manufacturing organization headquartered in bubendorf, switzerland. bachem specializes in the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients. in addition, biochemicals for research purposes and manufacturing processes are developed. the firm provides a number of products and services to the pharmaceutical and life science industries, including organic fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities and new chemical entities, and services for the bioscience sector.